tag:blogger.com,1999:blog-4241416962008169508.post7435512341815523335..comments2024-03-17T09:40:53.611-04:00Comments on Just A Life Sciences Blog...: [U] Barron's "Patent Expert": Merck v. Gilead -- We Agree, And We Said It All -- Many, Many Months AgoUnknownnoreply@blogger.comBlogger3125tag:blogger.com,1999:blog-4241416962008169508.post-85406298337498843472016-03-25T07:37:52.044-04:002016-03-25T07:37:52.044-04:00The royalties were capped at 4% of $5B in revenue...The royalties were capped at 4% of $5B in revenues so the total award is $200M.<br /><br />"The jury settled on a 4% royalty for $5B in sales, after subtracting a Gilead investment of $15B from the revenues."Anonymoushttps://www.blogger.com/profile/17562171569724628536noreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-49551827320765198542016-03-25T00:01:53.026-04:002016-03-25T00:01:53.026-04:00Thanks Anon. --
Yes Gilead will appeal. And as my...Thanks Anon. --<br /><br />Yes Gilead will appeal. And as my latest post of tonight indicates, the very able Judge Labson Freeman may reduce the jury award as early as next week -- based on her bench only trial (largely on whether the patents teach enough art to be this valuable, or whether much more patentable art is/was needed -- to make Solvaldi such a valuable finished drug).<br /><br />Me? I'm betting that the final number is well under $200 million.<br /><br />We shall see. Great comment!<br /><br />NamasteCondorhttp://shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-80175658335740932742016-03-24T23:53:21.781-04:002016-03-24T23:53:21.781-04:00This article left out that continued royalties of ...This article left out that continued royalties of 4% will still be rewarded to MRK. So, this is not over, as GILD will still appeal due to this.Anonymousnoreply@blogger.com